About Global Medical REIT (NYSE:GMRE)
Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.
Industry, Sector and Symbol:
- Debt-to-Equity Ratio: 0.72%
- Current Ratio: 0.22%
- Quick Ratio: 0.22%
Sales & Book Value:
- Trailing P/E Ratio: 23.95
- Forward P/E Ratio: 27.31
- P/E Growth: 2.97
- Annual Sales: $8.21 million
- Price / Sales: 25.19
- Book Value: $8.81 per share
- Price / Book: 1.09
- Annual Dividend: $0.80
- Dividend Yield: 8.6%
- Trailing EPS: ($0.20)
- Net Income: $-6,350,000.00
- Net Margins: -19.98%
- Return on Equity: -2.86%
- Return on Assets: -1.39%
- Employees: 10
- Outstanding Shares: 21,630,000
Frequently Asked Questions for Global Medical REIT (NYSE:GMRE)
What is Global Medical REIT's stock symbol?
Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."
How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?
Global Medical REIT declared a quarterly dividend on Friday, September 8th. Shareholders of record on Tuesday, September 26th will be paid a dividend of $0.20 per share on Monday, October 9th. This represents a $0.80 annualized dividend and a yield of 8.37%. The ex-dividend date of this dividend is Monday, September 25th. View Global Medical REIT's Dividend History.
How were Global Medical REIT's earnings last quarter?
Global Medical REIT Inc. (NYSE:GMRE) issued its quarterly earnings data on Thursday, May, 11th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by $0.24. The business had revenue of $4.66 million for the quarter, compared to analysts' expectations of $5.32 million. Global Medical REIT had a negative return on equity of 2.86% and a negative net margin of 19.98%. View Global Medical REIT's Earnings History.
When will Global Medical REIT make its next earnings announcement?
Where is Global Medical REIT's stock going? Where will Global Medical REIT's stock price be in 2017?
6 brokerages have issued 12 month price objectives for Global Medical REIT's stock. Their forecasts range from $10.00 to $12.00. On average, they anticipate Global Medical REIT's share price to reach $10.75 in the next year. View Analyst Ratings for Global Medical REIT.
What are Wall Street analysts saying about Global Medical REIT stock?
Here are some recent quotes from research analysts about Global Medical REIT stock:
- 1. According to Zacks Investment Research, "Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. " (11/14/2017)
- 2. FBR & Co analysts commented, "We are transferring coverage of Global Medical REIT to Bryan Maher due to a reallocation of research resources. Global Medical REIT is a young, albeit fast- growing, healthcare REIT that focuses on acquiring state-of-the-art medical office buildings (MOBs), outpatient and licensed medical facilities, which are leased to single tenants on a net lease basis. The portfolio currently encompasses 48 facilities, net leased to 39 tenants, and spans 1.12M square feet of leasable space. The facilities are among the youngest in the healthcare REIT universe (~12 years on average) and have an average of nine years remaining on their lease terms. The REIT recently completed a preferred share stock offering, netting ~$75M, which, when combined with existing cash, line availability, and leverage, could drive ~$200M in acquisitions over the next few quarters." (9/18/2017)
Who are some of Global Medical REIT's key competitors?
Some companies that are related to Global Medical REIT include A V Homes (AVHI), Health Insurance Innovations (HIIQ), Fidus Investment Corporation (FDUS), Urban&Civic plc (UANC), Allied Minds PLC (ALM), City Office REIT (CIO), First Financial Holdings (FFCH), Ares Commercial Real Estate Corporation (ACRE), Dynex Capital (DX), Carador Income Fund PLC (CIFU), Capital & Regional plc (CAL), Goldman Sachs MLP Income Opportunities Fund (GMZ), America First Multifamily Investors, L.P. (ATAX), Gladstone Investment Corporation (GAIN), C1 Financial (BNK), On Deck Capital (ONDK), Standard Life Investments Property Income Trust Limited (SLI) and Eagle Point Credit Company (ECC).
Who are Global Medical REIT's key executives?
Global Medical REIT's management team includes the folowing people:
- Jeffrey Busch, Chairman of the Board, President, Chief Executive Officer (Age 57)
- Robert J. Kiernan, Chief Financial Officer, Treasurer (Age 51)
- Danica Holley, Chief Operating Officer (Age 43)
- Mark W. Kennedy, Senior Vice President - Business Development
- Alfonzo Leon, Chief Investment Officer (Age 40)
- Conn Flanigan, General Counsel, Secretary (Age 48)
- Allen Webb, Executive Officer (Age 47)
- Henry Cole, Lead Independent Director (Age 71)
- Matthew Cypher Ph.D., Director
- Kurt R. Harrington, Director (Age 63)
When did Global Medical REIT IPO?
(GMRE) raised $130 million in an initial public offering on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.
Who owns Global Medical REIT stock?
Global Medical REIT's stock is owned by a number of of retail and institutional investors. Top institutional investors include Manning & Napier Advisors LLC (2.74%), Neuberger Berman Group LLC (1.19%), Bank of New York Mellon Corp (0.67%), RMR Advisors LLC (0.00%), Janney Montgomery Scott LLC (0.54%) and Stifel Financial Corp (0.52%). Company insiders that own Global Medical REIT stock include Henry Cole, Jeffrey Busch and Zh Usa, Llc. View Institutional Ownership Trends for Global Medical REIT.
Who sold Global Medical REIT stock? Who is selling Global Medical REIT stock?
Who bought Global Medical REIT stock? Who is buying Global Medical REIT stock?
Global Medical REIT's stock was acquired by a variety of institutional investors in the last quarter, including Stifel Financial Corp, Asset Management One Co. Ltd., Janney Montgomery Scott LLC, D.A. Davidson & CO., B. Riley Financial Inc., RMR Advisors LLC, BB&T Securities LLC and Sumitomo Mitsui Trust Holdings Inc.. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Jeffrey Busch and Zh Usa, Llc. View Insider Buying and Selling for Global Medical REIT.
How do I buy Global Medical REIT stock?
Shares of Global Medical REIT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Global Medical REIT's stock price today?
One share of Global Medical REIT stock can currently be purchased for approximately $9.56.
How big of a company is Global Medical REIT?
Global Medical REIT has a market capitalization of $202.03 million and generates $8.21 million in revenue each year. The company earns $-6,350,000.00 in net income (profit) each year or ($0.20) on an earnings per share basis. Global Medical REIT employs 10 workers across the globe.
How can I contact Global Medical REIT?
Global Medical REIT's mailing address is 4800 Montgomery Ln Ste 450, BETHESDA, MD 20814-3692, United States. The company can be reached via phone at +1-202-5246851.
MarketBeat Community Rating for Global Medical REIT (NYSE GMRE)MarketBeat's community ratings are surveys of what our community members think about Global Medical REIT and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Global Medical REIT (NYSE:GMRE) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 1 Hold Rating, 5 Buy Ratings, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 2.83)|
|Consensus Price Target: ||$10.75 (12.45% upside)|
Consensus Price Target History for Global Medical REIT (NYSE:GMRE)
Analysts' Ratings History for Global Medical REIT (NYSE:GMRE)
(Data available from 11/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|11/10/2017||B. Riley||Reiterated Rating||Buy||$10.50||N/A|
|9/18/2017||FBR & Co||Reiterated Rating||Buy||$10.00 -> $10.50||High|
|9/1/2017||Cantor Fitzgerald||Reiterated Rating||Overweight||$12.00||Medium|
|8/22/2017||DA Davidson||Downgrade||Buy -> Neutral||$11.00 -> $10.00||High|
|3/28/2017||Compass Point||Upgrade||Neutral -> Buy||Medium|
|2/23/2017||Janney Montgomery Scott||Initiated Coverage||Buy||N/A|
|11/10/2016||Wunderlich||Downgrade||Buy -> Hold||N/A|
|7/25/2016||Oppenheimer Holdings, Inc.||Initiated Coverage||Outperform||$12.00||N/A|
|7/11/2016||BB&T Corporation||Initiated Coverage||Hold||$10.50||N/A|
Earnings History and Estimates Chart for Global Medical REIT (NYSE:GMRE)
Earnings History by Quarter for Global Medical REIT (NYSE GMRE)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/26/2018|| || || || || || || || |
|8/10/2017||Q2 2017||$0.13||($0.04)||$6.16 million||$7.42 million||View||N/A|
|5/11/2017||Q1 2017||$0.10||($0.14)||$5.32 million||$4.66 million||View||N/A|
|3/27/2017||Q4 2016||($0.08)||($0.11)||$2.84 million||$3.12 million||View||N/A|
|11/10/2016||Q316||$0.04||($0.03)||$2.40 million||$2.00 million||View||N/A|
Earnings Estimates for Global Medical REIT (NYSE:GMRE)
2017 EPS Consensus Estimate: $0.16
2018 EPS Consensus Estimate: $0.77
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for Global Medical REIT (NYSE:GMRE)
|Most Recent Dividend:||10/9/2017|
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||-400.00% (Trailing 12 Months of Earnings) |
228.57% (Based on This Year's Estimates)
111.11% (Based on Next Year's Estimates)
Dividend History by Quarter for Global Medical REIT (NYSE GMRE)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Global Medical REIT (NYSE GMRE)
Insider Ownership Percentage: 16.51%
Institutional Ownership Percentage: 35.93%
Insider Trades by Quarter for Global Medical REIT (NYSE GMRE)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/14/2017||Henry Cole||Director||Buy||1,000||$9.30||$9,300.00|| |
|11/14/2017||Jeffrey Busch||Chairman||Buy||2,630||$9.29||$24,432.70|| |
|6/30/2017||Jeffrey Busch||Chairman||Buy||11,100||$9.00||$99,900.00|| |
|7/1/2016||Jeffrey Busch||Chairman||Buy||9,000||$10.01||$90,090.00|| |
|7/1/2016||Zh Usa, Llc||Major Shareholder||Buy||1,179,019||$12.75||$15,032,492.25|| |
Latest Headlines for Global Medical REIT (NYSE GMRE)
Financials are not available for this stock.
Global Medical REIT (NYSE GMRE) Chart for Tuesday, November, 21, 2017